Compare NTST & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTST | INVA |
|---|---|---|
| Founded | 2019 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2020 | 2004 |
| Metric | NTST | INVA |
|---|---|---|
| Price | $17.43 | $20.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | $20.27 | ★ $36.60 |
| AVG Volume (30 Days) | ★ 1.0M | 789.4K |
| Earning Date | 10-27-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.88% | N/A |
| EPS Growth | N/A | ★ 53.96 |
| EPS | 0.00 | ★ 1.52 |
| Revenue | $186,604,000.00 | ★ $388,521,000.00 |
| Revenue This Year | $17.52 | $13.23 |
| Revenue Next Year | $10.04 | $8.62 |
| P/E Ratio | $7,871.49 | ★ $13.53 |
| Revenue Growth | ★ 19.54 | 10.14 |
| 52 Week Low | $13.42 | $16.52 |
| 52 Week High | $19.64 | $22.76 |
| Indicator | NTST | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 36.26 | 42.95 |
| Support Level | $17.25 | $20.44 |
| Resistance Level | $17.85 | $21.00 |
| Average True Range (ATR) | 0.28 | 0.56 |
| MACD | -0.01 | -0.21 |
| Stochastic Oscillator | 15.91 | 5.29 |
Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.